Atezolizumab plus bevacizumab versus sorafenib or atezolizumab alone for unresectable hepatocellular carcinoma: A systematic review

por Ahmed, Faiza, Onwumeh-Okwundu, Jennifer, Yukselen, Zeynep, Endaya Coronel, Maria-Kassandra, Zaidi, Madiha, Guntipalli, Prathima, Garimella, Vamsi, Gudapati, Sravya, Mezidor, Marc Darlene, Andrews, Kim, Mouchli, Mohamad, Shahini, Endrit
Publicado 2021